425 related articles for article (PubMed ID: 16159951)
41. StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid.
Gollnick H; Luger T; Freytag S; Bräutigam M;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1319-25. PubMed ID: 18540990
[TBL] [Abstract][Full Text] [Related]
42. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
[TBL] [Abstract][Full Text] [Related]
43. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety.
McCaughey C; Machan M; Bennett R; Zone JJ; Hull CM
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1061-7. PubMed ID: 21175873
[TBL] [Abstract][Full Text] [Related]
44. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
Ozden MG; Tekin NS; Ilter N; Ankarali H
Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
[TBL] [Abstract][Full Text] [Related]
45. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.
Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M
J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
Delaporte E; Catteau B; Sabbagh N; Gosselin P; Breuillard F; Doutre MS; Broly F; Piette F; Bergoend H
Ann Dermatol Venereol; 1997; 124(2):151-6. PubMed ID: 9740825
[TBL] [Abstract][Full Text] [Related]
47. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
[TBL] [Abstract][Full Text] [Related]
48. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
49. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
[TBL] [Abstract][Full Text] [Related]
50. Pimecrolimus cream 1% is effective in asteatotic eczema: results of a randomized, double-blind, vehicle-controlled study in 40 patients.
Schulz P; Bunselmeyer B; Bräutigam M; Luger TA
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):90-4. PubMed ID: 17207174
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
52. Leflunomide in the treatment of psoriasis: results of a phase II open trial.
Tlacuilo-Parra JA; Guevara-Gutiérrez E; Rodríguez-Castellanos MA; Ornelas-Aguirre JM; Barba-Gómez JF; Salazar-Páramo M
Br J Dermatol; 2004 May; 150(5):970-6. PubMed ID: 15149511
[TBL] [Abstract][Full Text] [Related]
53. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.
Panahi Y; Moharamzad Y; Beiraghdar F; Naghizadeh MM
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):171-5. PubMed ID: 19143752
[TBL] [Abstract][Full Text] [Related]
54. A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index.
Pothinamthong P; Janjumratsang P
J Med Assoc Thai; 2012 Jul; 95(7):933-40. PubMed ID: 22919989
[TBL] [Abstract][Full Text] [Related]
55. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
Fleischer AB; Abramovits W; Breneman D; Jaracz E;
J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
[TBL] [Abstract][Full Text] [Related]
56. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
[TBL] [Abstract][Full Text] [Related]
57. Safety and efficacy of pimecrolimus cream 1% in the daily practice: results of a patient self-observation study in patients with atopic dermatitis.
Luger TA; Gollnick H; Schwennesen T; Bextermöller R; Freytag S; Bräutigam M
J Dtsch Dermatol Ges; 2007 Oct; 5(10):908-14. PubMed ID: 17910673
[TBL] [Abstract][Full Text] [Related]
58. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
[TBL] [Abstract][Full Text] [Related]
59. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
60. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]